Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management

Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management

Non-small-cell lung cancer (NSCLC) constitutes 85% of patients diagnosed with lung cancer. In metastatic cases, its treatment classically consists of systemic cytotoxic chemotherapy, which resulted in a median overall survival of 7.9 months. However, over the last decade, improved understanding of d...

Full description

Bibliographic Details
Main Authors: Akhil Rajendra, Vanita Noronha, Amit Joshi, Vijay Maruti Patil, Nandini Menon, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
egfr
lmic
nsclc
oral tki
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=36;epage=53;aulast=

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=36;epage=53;aulast=

Similar Items